compounded semaglutide glp-1 Hims & Hers launches drugs amid FDA warnings Compounded Semaglutide (GLP-1) Injections |

As research in this field continues to evolve, ongoing and future CVOTs will likely expand our knowledge of the cardiovascular benefits of GLP-1 receptor agonists, ultimately improving the care and outcomes of individuals with T2D and CVD

Both contain the same active ingredient and produce similar weight loss results

Our program is tailored for effectiveness across various age groups, including older adults

Side Effects of GLP-1 Agonists

Modern GLP-1 receptor agonists have demonstrated average weight loss of 15-20% of body weight with sustained treatment, representing a breakthrough in obesity pharmacotherapy that approaches the effectiveness of bariatric surgery